Skip to main content

An open-label, multiple dose, multicenter study to evaluate the pharmacokinetics, safety, and tolerability of filgotinib in children and adolescents from 8 to less than 18 years of age with juvenile idiopathic arthritis

Open
  • Protocol code: GLPG0634-CL-131
  • EudraCT code: No aplica
  • Research group: Rheumatology
  • Service: Internal Medicine
  • Principal investigator:  Lopez Corbeto, Mireia
  • Phase: Fase I
  • Status: Recruiting volunteers